- 00:08, 15 February 2021 (diff | hist) . . (+6,884) . . N User:ThaliaLovins153 (Created page with "In August, after an 18 to 6 panel recommendation, the FDA approved flibanserin for premenopausal women with warnings about side effects. Days after the decision, a Canadian co...") (current)